Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 07/26 05:35:21 pm
1667 GBp   +0.60%
07/22GLAXOSMITHKLINE : half-yearly earnings release
07/20DJBrexit Fears and Weak Pound Weigh on Corporate Europe
07/19 APPLE : GlaxoSmithKline partner for arthritis study
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2012 | 10:46am CEST

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
07/22 GLAXOSMITHKLINE PAKISTAN : Loss of Shares of GlaxoSmithKline Pakistan Limited
07/22GLAXOSMITHKLINE PLC : half-yearly earnings release
07/20DJBrexit Fears and Weak Pound Weigh on Corporate Europe
07/19 APPLE : GlaxoSmithKline partner for arthritis study
07/18 GLAXOSMITHKLINE : Glaxo's ViiV Sees Positive Results In Phase IIIb Triumeq Study
07/18 GLAXOSMITHKLINE : Glaxo Gets China Approval For Cervarix Cervical Cancer Vaccine
07/18DJGLAXOSMITHKLINE : China's Food and Drug Administration Approves GlaxoSmithKline'..
07/14 GLAXOSMITHKLINE : *exane bnp raises glaxosmithkline price target to 1530 pence -..
07/14 GLAXOSMITHKLINE : *jefferies raises glaxosmithkline to 'buy' (hold) - price targ..
07/13DJBusiness Watch -- WSJ
More news
Sector news : Pharmaceuticals - NEC
07/26 Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
07/26DJEli Lilly Revenue Rise Helped by New Products
07/26DJELI LILLY : Revenue Helped by Sales of New Drugs
07/26 Takeda sets bidding deadline for chemical firm stake, CVC and Carlyle may bid..
07/25DJSTADA ARZNEIMITTEL : Feels More Heat From Active Ownership
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/26 StarMine Models Pick European Companies For Earnings Beats
07/25 RETIREMENT STRATEGY : 5 Pharmaceutical Dividends To Buy Here
07/24 WEEK IN REVIEW : Cross-Border Investments Rule The News
07/22 SetPoint Off To A Good Start In The Clinic
07/21 Big Pharma Dominates Healthcare But Caregivers Are Top Sector Yield Dogs In J..
Advertisement
Financials ( GBP)
Sales 2016 26 368 M
EBIT 2016 6 707 M
Net income 2016 2 803 M
Debt 2016 12 843 M
Yield 2016 4,88%
P/E ratio 2016 31,99
P/E ratio 2017 23,25
EV / Sales 2016 3,55x
EV / Sales 2017 3,40x
Capitalization 80 735 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Average target price 16,4  GBP
Spread / Average Target -0,84%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Moncef Slaoui Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC20.68%105 867
JOHNSON & JOHNSON21.84%343 528
PFIZER INC.14.10%223 065
NOVARTIS AG-5.30%218 815
ROCHE HOLDING LTD.-9.99%217 668
MERCK & CO., INC.10.49%162 096
More Results